We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $12.8B
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+48.82%
3 Year Est. Return
+110.09%
5 Year Est. Return
+134.03%
10 Year Est. Return
+612.52%
AUM
$11.8B
AUM Growth
+$76M
Cap. Flow
-$34.6M
Cap. Flow %
-0.29%
Top 10 Hldgs %
11.39%
Holding
986
New
26
Increased
388
Reduced
338
Closed
13

Top Buys

Rank Stock Value
1
CFR icon
Cullen/Frost Bankers
CFR
+$45.7M
2
MEDP icon
Medpace
MEDP
+$45.2M
3
AIZ icon
Assurant
AIZ
+$29.9M
4
EPAC icon
Enerpac Tool Group
EPAC
+$23.9M
5
TILE icon
Interface
TILE
+$23.6M

Top Sells

Rank Stock Value
1
NSIT icon
Insight Enterprises
NSIT
+$29.6M
2
MANH icon
Manhattan Associates
MANH
+$23M
3
SYY icon
Sysco
SYY
+$21.4M
4
FIX icon
Comfort Systems
FIX
+$21.2M
5
PIPR icon
Piper Sandler
PIPR
+$19.7M

Sector Composition

Rank Sector Weight
1 Industrials 17.91%
2 Technology 17.69%
3 Healthcare 16.96%
4 Financials 14.09%
5 Consumer Discretionary 12.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVS icon
426
Las Vegas Sands
LVS
$29.6B
$73K ﹤0.01%
1,420
+17
+1% +$882
KLAC icon
427
KLA
KLAC
$272B
$72K ﹤0.01%
1,140
-30
-3% -$2.03K
HES
428
DELISTED
Hess
HES
$70K ﹤0.01%
529
+41
+8% +$5.72K
IWN icon
429
iShares Russell 2000 Value ETF
IWN
$14.6B
$69K ﹤0.01%
418
+254
+155% +$43.3K
WH icon
430
Wyndham Hotels & Resorts
WH
$5.49B
$68K ﹤0.01%
673
ANET icon
431
Arista Networks
ANET
$265B
$67K ﹤0.01%
604
+8
+1% +$823
BMY icon
432
Bristol-Myers Squibb
BMY
$130B
$67K ﹤0.01%
1,178
+111
+10% +$6.2K
FDX icon
433
FedEx
FDX
$77.3B
$67K ﹤0.01%
239
-2
-0.8% -$558
CTAS icon
434
Cintas
CTAS
$81.4B
$66K ﹤0.01%
362
+46
+15% +$9.67K
RPD icon
435
Rapid7
RPD
$827M
$66K ﹤0.01%
1,653
-19
-1% -$771
CI icon
436
Cigna
CI
$73.3B
$65K ﹤0.01%
236
-33
-12% -$10.5K
FISV
437
Fiserv Inc
FISV
$27.4B
$65K ﹤0.01%
314
+1
+0.3% +$204
LOW icon
438
Lowe's Companies
LOW
$121B
$64K ﹤0.01%
260
+5
+2% +$1.33K
PANW icon
439
Palo Alto Networks
PANW
$315B
$64K ﹤0.01%
351
+7
+2% +$1.32K
PEG icon
440
Public Service Enterprise Group
PEG
$37.8B
$64K ﹤0.01%
762
+9
+1% +$797
PNQI icon
441
Invesco NASDAQ Internet ETF
PNQI
$534M
$64K ﹤0.01%
+1,375
New +$63.1K
FCX icon
442
Freeport-McMoran
FCX
$96.9B
$63K ﹤0.01%
1,652
+29
+2% +$1.3K
CL icon
443
Colgate-Palmolive
CL
$73.6B
$62K ﹤0.01%
686
-1
-0.1% -$95
ELV icon
444
Elevance Health
ELV
$86.6B
$62K ﹤0.01%
167
+3
+2% +$1.25K
NEM icon
445
Newmont
NEM
$124B
$62K ﹤0.01%
1,673
-30
-2% -$1.37K
REGN icon
446
Regeneron Pharmaceuticals
REGN
$82.2B
$62K ﹤0.01%
87
SHOP icon
447
Shopify
SHOP
$194B
$62K ﹤0.01%
580
PYPL icon
448
PayPal
PYPL
$50.6B
$61K ﹤0.01%
720
+13
+2% +$1.09K
AVTR icon
449
Avantor
AVTR
$9.42B
$60K ﹤0.01%
2,825
BX icon
450
Blackstone
BX
$110B
$59K ﹤0.01%
342
+1
+0.3% +$174

Similar funds

GW&K Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, GW&K Investment Management held 986 positions worth $11.8B, up 0.65% from $11.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4%. GW&K Investment Management opened 26 new positions and exited 13, leaving the 986-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • GW&K Investment Management's largest Q4 2024 buy was Cullen/Frost Bankers: 347,838 shares worth $46.7M.
  • GW&K Investment Management added most to Medpace in Q4 2024, an estimated $45.2M increase.
  • GW&K Investment Management's biggest Q4 2024 reduction was Insight Enterprises, cutting an estimated $29.6M.
  • GW&K Investment Management fully exited Insperity in Q4 2024, selling an estimated $8.17M.
  • GW&K Investment Management's ten largest holdings make up 11% of its $11.8B portfolio in Q4 2024.
  • GW&K Investment Management opened 26 new positions and closed 13 in Q4 2024.
  • GW&K Investment Management's portfolio value rose 0.65% quarter-over-quarter to $11.8B.

Based on GW&K Investment Management's 13F filing for Q4 2024, filed 5 Feb 2025.